Na+/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin - PubMed (original) (raw)
. 2005 Jul 20;115(6):924-9.
doi: 10.1002/ijc.20959.
Affiliations
- PMID: 15729714
- DOI: 10.1002/ijc.20959
Na+/H+ exchanger activity is increased in doxorubicin-resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin
Erica Miraglia et al. Int J Cancer. 2005.
Abstract
Multidrug resistant (MDR) tumor cells exhibit an altered pH gradient across different cell compartments, which favors a reduced intracellular accumulation of antineoplastic drugs and a decreased therapeutic effect. In our study, we have observed that the activity and expression of Na+/H+ exchanger (NHE), which is involved in the homeostasis of intracellular pH (pHi), are increased in doxorubicin-resistant (HT29-dx) human colon carcinoma cells in comparison with doxorubicin-sensitive HT29 cells. The pH(i) was significantly higher in HT29-dx cells, which accumulated less doxorubicin than HT29 cells. The NHE inhibitor 5-(N-ethyl-N-isopropyl)amiloride (EIPA) significantly reduced the pHi value and increased the intracellular accumulation of doxorubicin in both cell populations: in the presence of EIPA HT29-dx cells accumulated as much drug as control HT29 cells. On the other hand, monensin, a Na+/H+ ionophore mimicking NHE activation, and phorbol 12-myristate 13-acetate (PMA), which stimulates NHE, significantly increased the pHi and decreased the drug accumulation in HT29 cells to values similar to those observed in control HT29-dx cells. EIPA potentiated the cytotoxic effect of doxorubicin in HT29 cells, and made HT29-dx cells as sensitive to the cytotoxic effect of the drug as control HT29 cells. Instead, PMA and monensin made HT29 cells as insensitive to doxorubicin as HT29-dx cells. These results suggest that in MDR cells the higher cytosolic pH is likely to decrease drug accumulation, and that such resistance can be reverted by inhibiting the NHE activity. This result opens the possibility to revert MDR with the clinical use of NHE inhibitors.
Copyright 2005 Wiley-Liss, Inc.
Similar articles
- Reversal of doxorubicin resistance by the amiloride analogue EIPA in multidrug resistant human colon carcinoma cells.
Pannocchia A, Revelli S, Tamponi G, Giorgianni A, Todde R, Bosia A, Ghigo D. Pannocchia A, et al. Cell Biochem Funct. 1996 Mar;14(1):11-8. doi: 10.1002/cbf.641. Cell Biochem Funct. 1996. PMID: 8907249 - Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.
Riganti C, Miraglia E, Viarisio D, Costamagna C, Pescarmona G, Ghigo D, Bosia A. Riganti C, et al. Cancer Res. 2005 Jan 15;65(2):516-25. Cancer Res. 2005. PMID: 15695394 - The role of Na+/H+ exchanger in serotonin secretion from porcine blood platelets.
Tomasiak M, Ciborowski M, Stelmach H. Tomasiak M, et al. Acta Biochim Pol. 2005;52(4):811-22. Epub 2005 Nov 7. Acta Biochim Pol. 2005. PMID: 16273125 - Intracellular pH regulation in U937 human monocytes: roles of V-ATPase and Na+/H+ exchange.
Heming TA, Bidani A. Heming TA, et al. Immunobiology. 2003;207(2):141-8. doi: 10.1078/0171-2985-00224. Immunobiology. 2003. PMID: 12675272
Cited by
- Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles.
Huntington KE, Louie A, Zhou L, Seyhan AA, Maxwell AW, El-Deiry WS. Huntington KE, et al. Am J Cancer Res. 2022 Jan 15;12(1):138-151. eCollection 2022. Am J Cancer Res. 2022. PMID: 35141009 Free PMC article. - Pyrazine ring-based Na+/H+ exchanger (NHE) inhibitors potently inhibit cancer cell growth in 3D culture, independent of NHE1.
Rolver MG, Elingaard-Larsen LO, Andersen AP, Counillon L, Pedersen SF. Rolver MG, et al. Sci Rep. 2020 Apr 2;10(1):5800. doi: 10.1038/s41598-020-62430-z. Sci Rep. 2020. PMID: 32242030 Free PMC article. - Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance.
Belisario DC, Kopecka J, Pasino M, Akman M, De Smaele E, Donadelli M, Riganti C. Belisario DC, et al. Cells. 2020 Dec 4;9(12):2598. doi: 10.3390/cells9122598. Cells. 2020. PMID: 33291643 Free PMC article. Review. - Proton Transport in Cancer Cells: The Role of Carbonic Anhydrases.
Becker HM, Deitmer JW. Becker HM, et al. Int J Mol Sci. 2021 Mar 20;22(6):3171. doi: 10.3390/ijms22063171. Int J Mol Sci. 2021. PMID: 33804674 Free PMC article. Review. - How Reciprocal Interactions Between the Tumor Microenvironment and Ion Transport Proteins Drive Cancer Progression.
Elingaard-Larsen LO, Rolver MG, Sørensen EE, Pedersen SF. Elingaard-Larsen LO, et al. Rev Physiol Biochem Pharmacol. 2022;182:1-38. doi: 10.1007/112_2020_23. Rev Physiol Biochem Pharmacol. 2022. PMID: 32737753 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources